Changes to COVID-19 prescribing rules
Comments: comments Print Friendly Version | Share this item
In October, NCMB issued orders to remove the drugs Tamiflu (oseltamivir) and azithromycin from administrative rules that set restrictions on medications prescribed for the treatment of COVID-19.
Please note that the rules do not prohibit a treating provider from prescribing any medication he or she believes may benefit a patient with COVID-19, as long as that patient has been diagnosed with the illness. The rules do prohibit the prescribing of certain medications to patients who do not have presumed or confirmed COVID-19, but wish to have medicine on hand in case they become ill.
The remaining restricted medications are:
(1) Hydroxychloroquine;
(2) Chloroquine;
(3) Lopinavir-ritonavir;
(4) Ribavirin; and
(5) Darunavir
Read the order amending prescribing rules for physicians and PAs.
Read the order amending prescribing rules for nurse practitioner.
Read the amended prescribing rules.
Please note that the rules do not prohibit a treating provider from prescribing any medication he or she believes may benefit a patient with COVID-19, as long as that patient has been diagnosed with the illness. The rules do prohibit the prescribing of certain medications to patients who do not have presumed or confirmed COVID-19, but wish to have medicine on hand in case they become ill.
The remaining restricted medications are:
(1) Hydroxychloroquine;
(2) Chloroquine;
(3) Lopinavir-ritonavir;
(4) Ribavirin; and
(5) Darunavir
Read the order amending prescribing rules for physicians and PAs.
Read the order amending prescribing rules for nurse practitioner.
Read the amended prescribing rules.
